09 May, 2026

What Akeso’s ASCO Plenary Says About Ivonescimab Survival Data

Adam Feuerstein is a senior biotechnology writer and columnist, reporting on the intersection of drug development, business, Wall Street and biotechnology. He is also co-host of the weekly biotechnology podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54. This is the online version of […]

2 mins read

Does coffee mix with AFib and other new data from heart meeting

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart disease, stroke and metabolic diseases. You can reach Liz on Signal at LizC.22. This is the online version of AHA in 30 seconds, tIt is the newest scientific session of the American Heart Association. Hello from New Orleans. Coming from Boston, running on the […]

1 min read

New Grail cancer test data shows progress but raises questions

As part of its bid to transform the future of cancer screening and take control of a potentially large and increasingly competitive market, Grail on Friday announced new data from a large U.S. study of its flagship blood test for detecting dozens of tumor types. The results reinforce some of the company’s arguments for a […]

1 min read

Apogee Therapeutics reports the first data on the drug in long -term eczema

Adam Feuerstein is a main writer and biotechnology columnist, reporting on the crossroads of drug development, business, Wall Street and biotechnology. He is also co-host of the weekly biotech podcast The Readout Loud and author of the Biotech dashboard of the Adam newsletter. You can reach Adam on the signal to stataf.54. Apogee Therapeutics said […]

1 min read